JoAnn E. Manson, MD, DrPH

Chief, Division of Preventive Medicine
Brigham and Womens Hospital
Professor of Medicine and the Michael and Lee Bell Professor of Womens Health
Harvard Medical School
900 Commonwealth Avenue, 3rd fl
Boston, Massachusetts 02215, USA

 

Biography

Dr. Manson is Chief of the Division of Preventive Medicine at Brigham and Womens Hospital (BWH) and the Michael and Lee Bell Professor of Womens Health and Professor of Medicine at Harvard Medical School. She is also Co-Director, Connors Center for Womens Health and Gender Biology, at BWH. Dr. Manson is an endocrinologist, epidemiologist, and Principal Investigator of several National Institute of Health-funded research studies, including the Womens Health Initiative Clinical Center, Boston site, since study inception; the VITamin D and OmegA-3 TriaL (VITAL); the Womens Folic Acid Cardiovascular Study, and the cardiovascular component of the Nurses Health Study, among others. She is also one of the Principal Investigators of the KEEPS trial and the Cocoa Supplement and Multivitamins Outcomes Study (COSMOS). She has received numerous honors, including the Woman in Science Award from the American Medical Womens Association, the American Heart Associations Population Research Prize, the AHAs Distinguished Scientist Award, election to the Institute of Medicine of the National Academies, and the 2013 Bernadine Healy Award for Visionary Leadership in Womens Health. She served as the 2011-2012 President of the North American Menopause Society (NAMS). She has published more than 800 articles and is the author or editor of several books. She was also one of the physicians featured in the National Library of Medicines exhibition, History of American Women Physicians.

Research Interest

Her primary research interests include Womens health, The role of lifestyle and nutritional factors in the prevention of cardiovascular disease, Effects of obesity on chronic diseases, the benefits and risks of estrogen therapy, vitamin D, omega-3s, and folic acid supplementation, and the effects of moderate-intensity versus vigorous exercise.

Scientific Activities

HONORS AND AWARDS

• (1978) Alpha Omega Alpha Honor Medical Society
• (1979-1982) Clinical Fellow in Medicine, Harvard Medical School, Boston, MA
• (1982-1984) Fellow in Endocrinology, University Hospital, Boston
• (1982) Diplomate of the American Board of Internal Medicine
• (1984-1987) Research Fellow in Medicine and Epidemiology, Brigham and Womens Hospital and Harvard Medical School, Boston
• (1987) Diplomate of the Am Board of Internal Med in the Subspecialty of Endocrinology and Metabolism
• (1991-1994) Assistant Professor of Medicine, Harvard Medical School, Boston
• (1993) Co-Director of Womens Health, and Director of Endocrinology, Division of Preventive Medicine, Brigham and Womens Hospital, Boston
• (1994-1999) Associate Professor of Medicine, Harvard Medical School, Boston
• (1996) Physician, Brigham and Womens Hospital, Boston
• (1996) Fellow of the American College of Endocrinology
• (1999) Mary Horrigan Connors Award for Outstanding Leadership in Womens Health
• (1999) Professor of Medicine, Harvard Medical School, Boston
• (1999) Chief, Division of Preventive Medicine, Brigham and Womens Hospital
• (2002) Co-Director, Connors Center for Womens Health and Gender Biology, Brigham and Womens
• (2003) Elizabeth Fay Brigham Endowed Professor of Womens Health, Harvard Medical School, Boston (renamed the Michael and Lee Bell Professorship in 2011)
• (2003) American Medical Womens Association, “Woman in Science Award”
• (2005) Elected member, Association of American Physicians
• (2010) American Heart Association Population Research Prize
• (2011) Elected to membership in the Institute of Medicine (IOM) of the National Academies
• (2011) American Heart Association, Distinguished Scientist Award

Publications

SELECTED PUBLICATIONS (SELECTED FROM OVER 700 PEER-REVIEWED PUBLICATIONS)

MOST RELEVANT TO THE CURRENT APPLICATION

1. Eaton CB, Abdulbaki AM, Margolis KL, et al. Racial and ethnic differences in incident hospitalized heart failure in post menopause women: The Womens Health Initiative. Circulation . 2012; 126(6): 688-696. doi: 10.1161/CIRCULATIONAHA.111.066688
2. Manson JE, Bassuk SS, Lee I-M, et al. The Vitamin D and Omega-3 Trial (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for primary prevention of cancer and cardiovascular disease. Contemp ClinTrials. 2012; 33(1): 159-171. doi: 10.1016/j.cct.2011.09.009
3. Manson JE, Hsia J, Johnson KC, et al. For the Womens Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003; 349: 523-534.
4. Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Womens Health Initiative randomized trials. JAMA. 2013; 310(13): 1353-1368. doi: 10.1001/jama.2013.278040
5. Levitan EB, Lewis CE, Tinker LF, et al. Mediterranean and DASH diet scores and mortality in women with heart failure: The Womens Health Initiative. Circ Heart Fail. 2013; 6: 1116-1123. doi: 10.1161/CIRCHEARTFAILURE.113.000495